Was the clinical trial for Pfizer’s mRNA-based gene-therapy “vaccine” fraudulent? Many are asking that question, and rightly so. Documents (read below) released in Nov. 2021 by the FDA as part of the court-mandated document dump show evidence of clinical trial enrollment at one particular trial site happening rapidly and just in time to meet the safety deadline for the FDA’s VRBPAC meeting on Dec. 10, 2020, to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 jab in indi...